Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/24/1995 | CA1334077C Monoclonal antibody recognizing human psti, hybridoma producing the antibody, and determination of human psti |
01/24/1995 | CA1334076C Monoclonal antibody recognizing atrial natriuretic polypeptide |
01/23/1995 | CA2128285A1 Monoclonal antibodies against prostate specific antigen that are not available in psa complexed to 1-antichymotrypsin |
01/21/1995 | CA2128399A1 Method for safety evaluation of chemical compound using recombinant yeast expressing human cytochrome p450 |
01/20/1995 | CA2128151A1 Receptors of interleukin-12 and antibodies |
01/19/1995 | WO1995002071A1 Selection and use of antiviral peptides |
01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
01/19/1995 | WO1995002067A1 Improved method for the quantification of nucleic acid |
01/19/1995 | WO1995002065A1 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
01/19/1995 | WO1995002060A1 Plants having modified growth characteristics |
01/19/1995 | WO1995002059A1 A dna construct encoding the yap3 signal peptide |
01/19/1995 | WO1995002058A2 BACILLUS THURINGIENSIS TRANSPOSON Tn5401 AND ITS USE IN A SITE-SPECIFIC RECOMBINATION SYSTEM FOR BACILLUS THURINGIENSIS STRAIN DEVELOPMENT |
01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
01/19/1995 | WO1995002056A2 Lettuce infectious yellows virus genes |
01/19/1995 | WO1995002055A1 Novel protein inhibitors of serine proteinases (e.g. furin) derived from turkey ovomucoid third domain |
01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
01/19/1995 | WO1995002053A1 Purified components of mammalian transcription regulation complexes, and analogs |
01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
01/19/1995 | WO1995002051A2 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
01/19/1995 | WO1995002050A1 Obtaining nucleic acids |
01/19/1995 | WO1995002049A1 Purification method and apparatus |
01/19/1995 | WO1995002048A1 Salmonella vaccines |
01/19/1995 | WO1995002044A1 An enzyme with protease activity |
01/19/1995 | WO1995002043A1 DNA ENCODING AN ENZYME WITH ENDOGLUCANASE ACTIVITY FROM $i(TRICHODERMA HARZIANUM) |
01/19/1995 | WO1995002042A1 (1 → 3, 1 → 4)-β-GLUCANASE OF ENHANCED STABILITY |
01/19/1995 | WO1995002040A2 New stromal cell lines from human bone marrow and their use |
01/19/1995 | WO1995002039A1 Stromal-cell lines from human bone marrow |
01/19/1995 | WO1995001998A3 Protein-enriched thermoplastics |
01/19/1995 | WO1995001998A2 Protein-enriched thermoplastics |
01/19/1995 | WO1995001994A1 Recombinant ctla4 polypeptides and methods for making the same |
01/19/1995 | WO1995001991A1 Allatostatins and their use |
01/19/1995 | WO1995001986A1 Dideoxyfructonucleotides and deoxyfructonucleotides as dna polymerase substrates |
01/19/1995 | WO1995001985A1 Auto-ligating oligonucleotide antisense compounds having diagnostic and therapeutic applications |
01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
01/19/1995 | WO1994026087A3 Recombinant protein production and insect cell culture and process |
01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
01/19/1995 | CA2166787A1 Salmonella vaccines |
01/19/1995 | CA2166786A1 Lettuce infectious yellows virus genes |
01/19/1995 | CA2166777A1 (1-3,1-4)-.beta.-glucanase of enhanced stability |
01/19/1995 | CA2166772A1 Purification method and apparatus |
01/19/1995 | CA2166684A1 A dna construct encoding the yap3 signal peptide |
01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
01/19/1995 | CA2165188A1 Selection and use of antiviral peptides |
01/19/1995 | CA2144319A1 Recombinant ctla4 polypeptides and methods for making the same |
01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
01/18/1995 | EP0634491A1 Modified oil content in seeds |
01/18/1995 | EP0634490A1 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
01/18/1995 | EP0634018A1 Method of detecting microorganisms |
01/18/1995 | EP0634017A1 IMMUNOASSAY FOR DETECTING HCV IgM ANTIBODY |
01/18/1995 | EP0634010A1 Electrophoresis of nucleic acid fragments |
01/18/1995 | EP0633945A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
01/18/1995 | EP0633944A1 Method of multiplex ligase chain reaction |
01/18/1995 | EP0633943A1 Gene therapy using targeted viral vectors |
01/18/1995 | EP0633942A1 Non-infectious hiv particles and uses therefor |
01/18/1995 | EP0633941A1 Synthetic eukaryotic promoters containing two inducible elements |
01/18/1995 | EP0633940A1 Oil-body protein cis-elements as regulatory signals |
01/18/1995 | EP0633939A1 Nisins |
01/18/1995 | EP0633938A1 Methods for producing substantially pure eg iii cellulase using alcohol |
01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
01/18/1995 | EP0633936A1 PROCESS FOR CONTROLLING SCARAB PESTS WITH $i(BACILLUS THURINGIENSIS) ISOLATES |
01/18/1995 | EP0633935A1 Stability-enhanced variants of parathyroid hormone |
01/18/1995 | EP0633934A1 Modified cells and method of treatment |
01/18/1995 | EP0633933A1 Leucine zippers |
01/18/1995 | EP0633932A1 DELIGNIFYING PREPARATION EXHIBITING $g(a)-L-ARABINOFURANOSIDASE ACTIVITY, PRODUCTION AND APPLICATION THEREOF |
01/18/1995 | EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
01/18/1995 | EP0633895A1 Oxygen carrier |
01/18/1995 | EP0633891A1 Synthesis of oligonucleotides. |
01/18/1995 | EP0633785A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
01/18/1995 | EP0633719A1 INDUCTION OF SOMATIC EMBRYOGENESIS IN $i(TAXUS), AND THE PRODUCTION OF TAXANE-RING CONTAINING ALKALOIDS THEREFROM |
01/18/1995 | EP0603307A4 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same. |
01/18/1995 | EP0580719A4 Methods for treating cotton-containing fabrics with cellulase. |
01/18/1995 | EP0577722A4 Methods for treating cotton-containing fabrics with cellulase. |
01/18/1995 | EP0576623A4 Binding domains in notch and delta proteins. |
01/18/1995 | EP0549686A4 Modified internucleoside linkages |
01/18/1995 | EP0406316B1 Peptides derived from Foot and mouth disease virus |
01/18/1995 | EP0394296B1 Assay of a body fluid for measuring bone resorption |
01/18/1995 | EP0378576B1 Transduced fibroblasts and uses therefor |
01/17/1995 | US5382660 TcpG gene of vibrio cholerae |
01/17/1995 | US5382658 Stability-enhanced variants of parathyroid hormone |
01/17/1995 | US5382527 Genetic engineering |
01/17/1995 | US5382524 Cloning and expression of biologically active α-n-acetylgalactosaminidase |
01/17/1995 | US5382521 Detection of cancer cells |
01/17/1995 | US5382519 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same |
01/17/1995 | US5382518 Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
01/17/1995 | US5382512 Assay device with captured particle reagent |
01/17/1995 | US5382510 Methods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53 |
01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
01/17/1995 | US5382438 Preparation of yogurt with lac(-) L. bulgaricus |
01/17/1995 | US5382429 Insecticides |
01/17/1995 | US5382425 Recombinant swinepox virus |
01/16/1995 | CA2127897A1 Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
01/12/1995 | WO1995001571A1 Process for the preparation of factor x depleted plasma |
01/12/1995 | WO1995001457A1 Htlv-iinra compositions and assays for detecting htlv infection |
01/12/1995 | WO1995001456A1 Oligonucleotide clamps having diagnostic and therapeutic applications |
01/12/1995 | WO1995001454A1 Method for detection of susceptibility mutations for ototoxic deafness |
01/12/1995 | WO1995001448A1 A method for introducing a biological substance into a target |